One Shot, Two Years of Lower Cholesterol: Scribe's CRISPR Gene Therapy Begins Human Trials
· techtimes.com · popularity 19/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at techtimes.com →
Summary
Scribe's CRISPR gene therapy held cholesterol down for two years from one shot — entering human trials the day pelacarsen failed its Phase 3 trial.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 8.